Showing results (1-10 of 12,899) with videos related to
Sort By:
Pageof 1,290
Journal of Thrombosis and Thrombolysis|January 1, 1994
Time as an Adjunctive Agent to Thrombolytic TherapyCannon, Antman, Walls, et al.Journal of Thrombosis and Thrombolysis|January 1, 1996
Time to Reperfusion: The Critical Modulator in Thrombolysis and Primary AngioplastyCannon, BraunwaldThe American Journal of Cardiology|September 18, 2004
Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS)David A Morrow, Marc S Sabatine, Elliott M Antman, et al.Journal of the American College of Cardiology|February 14, 1998
Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudyE M Antman, D B Sacks, N Rifai, et al.American Heart Journal|February 9, 2002
Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial InfarctionElliott M Antman, Carolyn H McCabe, Eugene BraunwaldJournal of the American College of Cardiology|June 1, 1995
Hirudin: initial results in acute myocardial infarction, unstable angina and angioplastyC P Cannon, E BraunwaldCritical Pathways in Cardiology|March 15, 2008
Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) acute coronary syndromes Critical Pathway ToolkitChristopher P Cannon, Eugene Braunwald, Journal of the American College of Cardiology|June 17, 1998
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial InfarctionD A Morrow, N Rifai, E M Antman, et al.Journal of the American College of Cardiology|October 22, 2013
Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38)Payal Kohli, Jacob A Udell, Sabina A Murphy, et al.Journal of the American College of Cardiology|February 17, 2000
Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudyD A Morrow, N Rifai, E M Antman, et al.Pageof 1,290